According to Enanta Pharmaceuticals
's latest financial reports the company has $0.19 B in net assets.
A companyโs net assets is the sum of its assets minus the sum of its liabilities.
Year | Net assets | Change |
---|---|---|
2023-09-30 | $0.21 B | -32.55% |
2022-09-30 | $0.32 B | -19.55% |
2021-09-30 | $0.39 B | -12.33% |
2020-09-30 | $0.45 B | -1.49% |
2019-09-30 | $0.46 B | 17.48% |
2018-09-30 | $0.39 B | 30.5% |
2017-09-30 | $0.30 B | 11.76% |
2016-09-30 | $0.26 B | 14.3% |
2015-09-30 | $0.23 B | 58.86% |
2014-09-30 | $0.14 B | 34.57% |
2013-09-30 | $0.11 B | 151.47% |
2012-09-30 | $43.92 M | 100.1% |
2011-09-30 | $21.95 M |
Company | Net assets | differencediff. | Country |
---|---|---|---|
Johnson & Johnson JNJ | $68.77 B | 35,741.45% | ๐บ๐ธ USA |
Novartis NVS | $39.75 B | 20,618.77% | ๐จ๐ญ Switzerland |
AbbVie ABBV | $10.39 B | 5,318.38% | ๐บ๐ธ USA |
Vertex Pharmaceuticals VRTX | $17.58 B | 9,061.99% | ๐บ๐ธ USA |
Merck MRK | $37.63 B | 19,513.41% | ๐บ๐ธ USA |
Bristol-Myers Squibb BMY | $16.54 B | 8,523.96% | ๐บ๐ธ USA |